“Hemp-derived” is a starting point for a product review, not a complete explanation of what your business can sell or which provider can process it. The formulation, manufacturing method, intended use, marketing and destination all matter. In September 2026, owners also need a transition plan that does not rely on an outdated federal deadline.
For CBD payment processing, the useful question is specific: which products, sold through which channels, to which destinations, under which reviewed requirements? A catalog that answers those questions makes the merchant-services conversation more productive and gives staff an operating record they can maintain.
By the Stratamize team. U.S. federal status checked September 21, 2026; state and local product rules require separate review. This is operational education, not a product-specific legal opinion.
The federal transition has two dates
Section 781 of the November 12, 2025 law rewrote the federal hemp definition, originally effective 365 days after enactment. Among its changes are total-THC treatment including THCA, exclusions involving manufactured cannabinoids, and a final-product exclusion above 0.4 milligrams per container of the specified combined cannabinoids. The provision is not merely a delta-9 percentage test. Read section 781 of Public Law 119-37.
A subsequent change matters: H.R. 6500 was signed September 2, 2026. Its section 2019 defers most section 781 changes until December 11, 2026. The original November 12 timing remains relevant for the intermediate and final products specified in the carve-out: those containing cannabinoids that the cannabis plant cannot naturally produce. See the enrolled act, section 2019.
That does not make every currently stocked product lawful until December. Existing federal, state and local requirements still matter. Have counsel map each formulation to the applicable provision and date; avoid treating every product described as “synthetic” as legally identical.
Turn the calendar into a catalog decision
Create one review row for each actual product, rather than one row for an entire brand. Include the ingredient list, cannabinoid profile, container size, manufacturing explanation, current label, intended use, supplier and matching laboratory evidence. A report for a different lot or bottle size cannot answer every question about what is on your shelf.
Add a field for the next decision: continue review, request missing evidence, restrict destinations or stop offering the item under your reviewed plan. Assign an owner and a deadline. The document should tell purchasing, customer support and website staff what to do when a product changes.
This is an operating recommendation, not a universal documentation rule. It makes a difficult conversation concrete. Your adviser can identify the legal issue, your supplier can address the formulation, and your processor can evaluate the accurately described business.
Hemp status does not settle FDA requirements
FDA separately states that CBD and THC products are excluded from the dietary supplement definition under the circumstances described in its guidance, and that introducing food with added CBD or THC into interstate commerce is prohibited under its stated interpretation. Hemp status does not remove those requirements. See FDA's cannabis and CBD questions 8 through 10.
Do not present a gummy, beverage, topical and seed ingredient as interchangeable simply because each sits in a hemp catalog. Ask your adviser to review the actual intended use and customer-facing claims. Keep screenshots of the reviewed product pages so a later marketing edit does not quietly change the product story presented during underwriting.
The payment task follows that review. A checkout integration cannot cure an unsupported legal conclusion, and an available processor does not establish that a particular formulation or claim is permitted.
Prepare underwriting around the complete business
A useful account package tells a consistent story across the website, labels and application. Explain whether you manufacture, private-label, distribute or retail. Identify subscription offers, marketplaces, affiliates, fulfillment partners and every website where customers pay.
Bring available processing history and a plain explanation of returns, disputes and unusual volume changes. For a new operation, separate forecasts from established results. If a previous provider restricted the account, include its notice and the affected products instead of removing them from the narrative.
Ask prospective providers to describe the approved catalog and channels, any review conditions, and the process for notifying them about changes. Ask how reserves, funding schedules, termination provisions and refunds work under the proposed agreement. Evaluate those terms against your actual purchasing and fulfillment cycle; approval alone is not the entire commercial decision.
Design checkout for changes after launch
Imagine a product's review status changes after an order is placed. Can staff find affected unfulfilled orders? Can they stop a scheduled repeat order for that specific item? Can they explain a cancellation and match the refund to the original payment?
Those are useful integration requirements. Connect product status to the order system and define who can release an exception. Keep the payment result, fulfillment result and customer communication visible without merging them into a single “complete” label.
If your catalog spans several product categories, test mixed baskets too. A blocked item should not quietly reappear through a saved cart, a subscription renewal or a staff-created invoice. These checks help implement the requirements your advisers and provider have established.
Owner checklist for the next review
- List each formulation, container size, supplier and intended use.
- Match available laboratory evidence to the actual product and lot.
- Review the November and December transition provisions product by product.
- Establish destination restrictions from current state and local requirements.
- Align labels, advertising, checkout and underwriting descriptions.
- Confirm how product changes reach purchasing, subscriptions and fulfillment.
- Review account terms and refund access before committing to an integration.
CBD and hemp merchant account questions
Is every restriction delayed until December 11?
No. Section 2019 has a specific carve-out. Use the actual statutory categories with counsel rather than relying on a headline about a general delay.
Does a certificate of analysis guarantee processing?
No. Laboratory evidence supports part of the product review. Intended use, claims, destinations, business operations and provider criteria also affect the assessment.
Can the existing website remain in place?
Often the first step is assessing its capabilities. Identify where product restrictions, order holds and refunds need to connect before deciding whether configuration or development is required.
Make the consultation product-specific
Stratamize helps organize CBD and hemp merchant account reviews and scope payment connections around a qualifying business. Bring your catalog, current software and documented legal review questions. Book with Joseph to turn those details into a preparation and integration plan, with account availability determined by underwriting.